I am a passionate researcher and academician specializing in structural biology, biochemistry, and computer-aided drug discovery (CADD) with a strong focus on neurodegenerative and cancer therapeutics. Over the years, my work has centered on understanding the molecular mechanisms of disease and translating these insights into novel therapeutic strategies.
With extensive experience in computational and experimental pharmacology, I have contributed to multiple high-impact international publications and collaborations across leading research institutions. My research integrates structural bioinformatics, molecular modeling, and biochemical and pharmacological validation to accelerate the identification and optimization of drug candidates targeting key disease pathways.
Currently, my efforts are directed toward building interdisciplinary collaborations that bridge computational and clinical sciences to advance precision and personalized medicine. I aim to foster partnerships between academia, industry, and clinical researchers to translate molecular discoveries into tangible therapeutic interventions.
I am deeply committed to nurturing the next generation of scientists, promoting innovation in drug design, and contributing to the global research ecosystem through impactful collaborations and scientific outreach.
Open to research partnerships, joint grant proposals, and interdisciplinary projects in computational drug discovery, neurodegenerative disorders, and cancer biology.